Compare Eureka Prima Jakarta Tbk. (LCGP) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eureka Prima Jakarta Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Eureka Prima Jakarta Tbk. trades at Rp114 (market cap 641.82B), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Eureka Prima Jakarta Tbk. is far larger — about 6.1× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| LCGP | SCPI | |
|---|---|---|
Market Cap | 641.82B | 104.4B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eureka Prima Jakarta Tbk.
PT Eureka Prima Jakarta Tbk formerly Laguna Cipta Griya Tbk (the company) was established based on notarial deed No. 97 dated May 17, 20014 of Bambang Suwondo, S.H., notary in Jakarta and has been amended based on the deed No. 4 dated June 4, 2004 before notary H. Yunardi, S.H. The Company’s articles of association has been amended several times, most recently by notarial deed No. 40 of Fathiah Helmi, S.H., dated Jan 30, 2007, concerning among others, change the company's name.
Read more on LCGP →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
